{"version":"1.0","type":"link","title":"Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age.","author_name":"Shore ND 외","author_url":"https://prs-insight.online/author/Shore%20ND","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/133287","thumbnail_width":1200,"thumbnail_height":630}